Anthem Biosciences Limited (BOM:544449)

India flag India · Delayed Price · Currency is INR
817.30
-17.90 (-2.14%)
At close: Aug 28, 2025
-2.14%
Market Cap459.43B
Revenue (ttm)20.52B
Net Income (ttm)5.05B
Shares Outn/a
EPS (ttm)8.99
PE Ratio91.03
Forward PE73.79
Dividendn/a
Ex-Dividend Daten/a
Volume62,943
Average Volume150,975
Open848.65
Previous Close835.20
Day's Range815.35 - 848.65
52-Week Range701.75 - 865.00
Betan/a
RSI56.33
Earnings DateAug 13, 2025

About Anthem Biosciences

Anthem Biosciences Limited operates as technology-focused contract research, development, and manufacturing organization. It operates through two segments: Contract Research, Development & Manufacturing (CRDMO) services; and Speciality Ingredients. The company offers end-to-end services across the new chemical entity and new biological entity lifecycles, including target identification and the concept stage; preclinical development; and manufacturing development batches of molecules used for clinical Phase I, II, and III trials up to commercial... [Read more]

Industry Commercial Physical and Biological Research
Founded 2006
Employees 1,825
Stock Exchange Bombay Stock Exchange
Ticker Symbol 544449
Full Company Profile

Financial Performance

In 2024, Anthem Biosciences's revenue was 18.50 billion, an increase of 30.29% compared to the previous year's 14.20 billion. Earnings were 4.51 billion, an increase of 22.86%.

Financial Statements

News

There is no news available yet.